Increased brain expression of tryptophan 2,3-dioxygenase (TDO), one of the enzymes in the first step of the pathway, has also been linked to Alzheimer's disease in transgenic mice and human tissue (Wu et al., 2013). The gene discussed is TDO2; the disease is early-onset autosomal dominant Alzheimer disease.